Welcome to our dedicated page for IonQ SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ Executive Chair Peter Chapman reported significant insider transactions on June 20, 2025, executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025.
Key transaction details:
- Exercised 1,497,311 employee stock options at $0.1334 per share
- Subsequently sold the same number of shares at a weighted average price of $39.931 (range: $39.50-$41.40)
- Post-transaction holdings: 390,329 shares held directly and 107,661 remaining stock options
The transactions were executed under a Rule 10b5-1 plan, which provides a safe harbor from insider trading allegations by establishing predetermined trading parameters. Chapman's remaining stock options are fully vested and exercisable, with an expiration date of May 16, 2029.
IonQ, Inc. (IONQ) has filed a Form 144 indicating an additional insider share sale. Peter Chapman intends to sell 1,497,311 shares of common stock through Merrill Lynch on or about 20 June 2025 on the NYSE. Based on the filing, IonQ has 261.6 million shares outstanding, so the proposed sale represents roughly 0.6 % of shares outstanding.
The filing also discloses that Chapman has already disposed of 4,491,933 shares in the past three months in two separate transactions dated 16 and 17 June 2025, generating US$171 million in gross proceeds. Taken together, recent and proposed sales total about 5.99 million shares, or ~2.3 % of outstanding stock.
All shares derive from stock-option exercises originally acquired on 17 Nov 2019. No material adverse, non-public information is acknowledged by the filer, and the sale may be conducted under a Rule 10b5-1 trading plan (date not provided). Apart from the sale notice, the document contains no operating metrics, earnings data, or strategic commentary.
Key datapoints
- Shares to be sold: 1,497,311
- Aggregate market value of proposed sale: US$59.7 million
- Broker: Merrill Lynch, San Francisco
- Issuer shares outstanding: 261.6 million
- Prior 3-month insider sales: 4.49 million shares for US$171 million
The elevated volume of insider selling, especially by a key executive, can signal reduced confidence or simple diversification; investors typically interpret sizeable Form 144 activity as a modest negative indicator unless offset by compelling corporate developments.